Posts Tagged ‘Hemophilia’

OBI-1 Developed By Ipsen And Inspiration Has Obtained A Positive Opinion For The Orphan Drug Status In Europe

Commentary: Why We Need Better Drug Monitoring

Irish Government Launches Program To Provide Life Insurance To People With HIV, Hepatitis C Through Contaminated Blood Products

Biogen Idec And Swedish Orphan Biovitrum Announce First Patient Dosed In Global Registrational Trial Of Long-Acting Hemophilia B Therapy

Ipsen’s Partner Inspiration Biopharmaceuticals Announces Non-Inferiority Of IB1001, Its Recombinant Factor IX For Hemophilia B

New Data To Be Presented At The World Federation Of Hemophilia 2010 Congress

The Product Portfolio Strategy As Decisive Force In Forming The Future Coagulation Factor Market

Helixate FS Receives FDA Approval For Routine Prophylaxis In Children With Hemophilia A

Beriplex® P/N Provides Fast, Predictable And Safe Anti-Coagulation Reversal, According To Study

PTC Therapeutics Initiates Phase 2 Clinical Trial Of Ataluren (PTC124(R)) In Patients With Hemophilia

Tag Cloud